Korean guidelines for the prevention of venous thromboembolism

This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Korean medical science 2010, 25(11), 144, pp.1553-1559
Main Authors: Bang, Soo-Mee, Jang, Moon Ju, Oh, Doyeun, Kim, Yeo-Kyeoung, Kim, In Ho, Yoon, Sung-Soo, Yoon, Hwi-Joong, Kim, Chul-Soo, Park, Seonyang
Format: Article
Language:English
Subjects:
Heparin, Low-Molecular-Weight - therapeutic use
Humans
Polysaccharides - therapeutic use
Republic of Korea
Risk Factors
Special
Venous Thromboembolism - prevention & control
Venous Thromboembolism - surgery
Venous Thromboembolism - therapy
Warfarin - therapeutic use
의학일반
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-4a10a6297874df0d20859b5089b7e856db47c53cfd99322d385b22898f3b5e723
cites cdi_FETCH-LOGICAL-c440t-4a10a6297874df0d20859b5089b7e856db47c53cfd99322d385b22898f3b5e723
container_end_page 1559
container_issue 11
container_start_page 1553
container_title Journal of Korean medical science
container_volume 25
creator Bang, Soo-Mee
Jang, Moon Ju
Oh, Doyeun
Kim, Yeo-Kyeoung
Kim, In Ho
Yoon, Sung-Soo
Yoon, Hwi-Joong
Kim, Chul-Soo
Park, Seonyang
description This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently, no nation-wide data on the incidence of VTE exist, and randomized controlled trials aiming at the prevention of VTE in Korea have yielded few results. Therefore, these guidelines were based on the second edition of the Japanese Guidelines for the Prevention of VTE and the eighth edition of the American College of Chest Physicians (ACCP) Evidenced-Based Clinical Practice Guidelines. These guidelines establish low-, moderate-, and high-risk groups, and recommend appropriate thromboprophylaxis for each group.
doi_str_mv 10.3346/jkms.2010.25.11.1553
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_573971</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>763256118</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-4a10a6297874df0d20859b5089b7e856db47c53cfd99322d385b22898f3b5e723</originalsourceid><addsrcrecordid>eNpVkVlLAzEUhYMotlb_gci86cvU7MtLoRSXYkGQ-hxmybRpZyY1aQv-e9PFog_h3nDPOVk-AG4R7BNC-eNi2YQ-hnGLWR-hPmKMnIEuYkqmnDBxHnuIUCoVoR1wFcICQswYJpeggxHkUFDcBYM3503WJrONLU1tWxOSyvlkPTfJyputadfWtYmrkti6TYgD75rcmbhqG5prcFFldTA3x9oDn89P09FrOnl_GY-Gk7SgFK5TmiGYcayEFLSsYImhZCpnUKpcGMl4mVNRMFJUpVIE45JIlmMslaxIzozApAceDrmtr_SysNpldl9nTi-9Hn5Mx5oJogSK0sFButrkjSmL-ASf1XrlbZP5773x_6S18xiz1VhxrhSMAffHAO--NiasdWNDYeo6a038Ai04wYwjJKOSHpSFdyF4U51OQVDvIOkdJL2DpDHTCOkdpGi7-3vDk-mXCvkBPV6OtA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763256118</pqid></control><display><type>article</type><title>Korean guidelines for the prevention of venous thromboembolism</title><source>PubMed (Medline)</source><creator>Bang, Soo-Mee ; Jang, Moon Ju ; Oh, Doyeun ; Kim, Yeo-Kyeoung ; Kim, In Ho ; Yoon, Sung-Soo ; Yoon, Hwi-Joong ; Kim, Chul-Soo ; Park, Seonyang</creator><creatorcontrib>Bang, Soo-Mee ; Jang, Moon Ju ; Oh, Doyeun ; Kim, Yeo-Kyeoung ; Kim, In Ho ; Yoon, Sung-Soo ; Yoon, Hwi-Joong ; Kim, Chul-Soo ; Park, Seonyang ; Korean Society of Thrombosis and Hemostasis</creatorcontrib><description>This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently, no nation-wide data on the incidence of VTE exist, and randomized controlled trials aiming at the prevention of VTE in Korea have yielded few results. Therefore, these guidelines were based on the second edition of the Japanese Guidelines for the Prevention of VTE and the eighth edition of the American College of Chest Physicians (ACCP) Evidenced-Based Clinical Practice Guidelines. These guidelines establish low-, moderate-, and high-risk groups, and recommend appropriate thromboprophylaxis for each group.</description><identifier>ISSN: 1011-8934</identifier><identifier>EISSN: 1598-6357</identifier><identifier>DOI: 10.3346/jkms.2010.25.11.1553</identifier><identifier>PMID: 21060742</identifier><language>eng</language><publisher>Korea (South): The Korean Academy of Medical Sciences</publisher><subject>Heparin, Low-Molecular-Weight - therapeutic use ; Humans ; Polysaccharides - therapeutic use ; Republic of Korea ; Risk Factors ; Special ; Venous Thromboembolism - prevention &amp; control ; Venous Thromboembolism - surgery ; Venous Thromboembolism - therapy ; Warfarin - therapeutic use ; 의학일반</subject><ispartof>Journal of Korean Medical Science, 2010, 25(11), 144, pp.1553-1559</ispartof><rights>2010 The Korean Academy of Medical Sciences. 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-4a10a6297874df0d20859b5089b7e856db47c53cfd99322d385b22898f3b5e723</citedby><cites>FETCH-LOGICAL-c440t-4a10a6297874df0d20859b5089b7e856db47c53cfd99322d385b22898f3b5e723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966990/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966990/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21060742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001492574$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Bang, Soo-Mee</creatorcontrib><creatorcontrib>Jang, Moon Ju</creatorcontrib><creatorcontrib>Oh, Doyeun</creatorcontrib><creatorcontrib>Kim, Yeo-Kyeoung</creatorcontrib><creatorcontrib>Kim, In Ho</creatorcontrib><creatorcontrib>Yoon, Sung-Soo</creatorcontrib><creatorcontrib>Yoon, Hwi-Joong</creatorcontrib><creatorcontrib>Kim, Chul-Soo</creatorcontrib><creatorcontrib>Park, Seonyang</creatorcontrib><creatorcontrib>Korean Society of Thrombosis and Hemostasis</creatorcontrib><title>Korean guidelines for the prevention of venous thromboembolism</title><title>Journal of Korean medical science</title><addtitle>J Korean Med Sci</addtitle><description>This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently, no nation-wide data on the incidence of VTE exist, and randomized controlled trials aiming at the prevention of VTE in Korea have yielded few results. Therefore, these guidelines were based on the second edition of the Japanese Guidelines for the Prevention of VTE and the eighth edition of the American College of Chest Physicians (ACCP) Evidenced-Based Clinical Practice Guidelines. These guidelines establish low-, moderate-, and high-risk groups, and recommend appropriate thromboprophylaxis for each group.</description><subject>Heparin, Low-Molecular-Weight - therapeutic use</subject><subject>Humans</subject><subject>Polysaccharides - therapeutic use</subject><subject>Republic of Korea</subject><subject>Risk Factors</subject><subject>Special</subject><subject>Venous Thromboembolism - prevention &amp; control</subject><subject>Venous Thromboembolism - surgery</subject><subject>Venous Thromboembolism - therapy</subject><subject>Warfarin - therapeutic use</subject><subject>의학일반</subject><issn>1011-8934</issn><issn>1598-6357</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpVkVlLAzEUhYMotlb_gci86cvU7MtLoRSXYkGQ-hxmybRpZyY1aQv-e9PFog_h3nDPOVk-AG4R7BNC-eNi2YQ-hnGLWR-hPmKMnIEuYkqmnDBxHnuIUCoVoR1wFcICQswYJpeggxHkUFDcBYM3503WJrONLU1tWxOSyvlkPTfJyputadfWtYmrkti6TYgD75rcmbhqG5prcFFldTA3x9oDn89P09FrOnl_GY-Gk7SgFK5TmiGYcayEFLSsYImhZCpnUKpcGMl4mVNRMFJUpVIE45JIlmMslaxIzozApAceDrmtr_SysNpldl9nTi-9Hn5Mx5oJogSK0sFButrkjSmL-ASf1XrlbZP5773x_6S18xiz1VhxrhSMAffHAO--NiasdWNDYeo6a038Ai04wYwjJKOSHpSFdyF4U51OQVDvIOkdJL2DpDHTCOkdpGi7-3vDk-mXCvkBPV6OtA</recordid><startdate>20101101</startdate><enddate>20101101</enddate><creator>Bang, Soo-Mee</creator><creator>Jang, Moon Ju</creator><creator>Oh, Doyeun</creator><creator>Kim, Yeo-Kyeoung</creator><creator>Kim, In Ho</creator><creator>Yoon, Sung-Soo</creator><creator>Yoon, Hwi-Joong</creator><creator>Kim, Chul-Soo</creator><creator>Park, Seonyang</creator><general>The Korean Academy of Medical Sciences</general><general>대한의학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>20101101</creationdate><title>Korean guidelines for the prevention of venous thromboembolism</title><author>Bang, Soo-Mee ; Jang, Moon Ju ; Oh, Doyeun ; Kim, Yeo-Kyeoung ; Kim, In Ho ; Yoon, Sung-Soo ; Yoon, Hwi-Joong ; Kim, Chul-Soo ; Park, Seonyang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-4a10a6297874df0d20859b5089b7e856db47c53cfd99322d385b22898f3b5e723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Heparin, Low-Molecular-Weight - therapeutic use</topic><topic>Humans</topic><topic>Polysaccharides - therapeutic use</topic><topic>Republic of Korea</topic><topic>Risk Factors</topic><topic>Special</topic><topic>Venous Thromboembolism - prevention &amp; control</topic><topic>Venous Thromboembolism - surgery</topic><topic>Venous Thromboembolism - therapy</topic><topic>Warfarin - therapeutic use</topic><topic>의학일반</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bang, Soo-Mee</creatorcontrib><creatorcontrib>Jang, Moon Ju</creatorcontrib><creatorcontrib>Oh, Doyeun</creatorcontrib><creatorcontrib>Kim, Yeo-Kyeoung</creatorcontrib><creatorcontrib>Kim, In Ho</creatorcontrib><creatorcontrib>Yoon, Sung-Soo</creatorcontrib><creatorcontrib>Yoon, Hwi-Joong</creatorcontrib><creatorcontrib>Kim, Chul-Soo</creatorcontrib><creatorcontrib>Park, Seonyang</creatorcontrib><creatorcontrib>Korean Society of Thrombosis and Hemostasis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Journal of Korean medical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bang, Soo-Mee</au><au>Jang, Moon Ju</au><au>Oh, Doyeun</au><au>Kim, Yeo-Kyeoung</au><au>Kim, In Ho</au><au>Yoon, Sung-Soo</au><au>Yoon, Hwi-Joong</au><au>Kim, Chul-Soo</au><au>Park, Seonyang</au><aucorp>Korean Society of Thrombosis and Hemostasis</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Korean guidelines for the prevention of venous thromboembolism</atitle><jtitle>Journal of Korean medical science</jtitle><addtitle>J Korean Med Sci</addtitle><date>2010-11-01</date><risdate>2010</risdate><volume>25</volume><issue>11</issue><spage>1553</spage><epage>1559</epage><pages>1553-1559</pages><issn>1011-8934</issn><eissn>1598-6357</eissn><abstract>This guideline focuses on the primary prevention of venous thromboembolism (VTE) in Korea. The guidelines should be individualized and aim at patients scheduled for major surgery, as well as patients with a history of trauma, high-risk pregnancy, cancer, or other severe medical illnesses. Currently, no nation-wide data on the incidence of VTE exist, and randomized controlled trials aiming at the prevention of VTE in Korea have yielded few results. Therefore, these guidelines were based on the second edition of the Japanese Guidelines for the Prevention of VTE and the eighth edition of the American College of Chest Physicians (ACCP) Evidenced-Based Clinical Practice Guidelines. These guidelines establish low-, moderate-, and high-risk groups, and recommend appropriate thromboprophylaxis for each group.</abstract><cop>Korea (South)</cop><pub>The Korean Academy of Medical Sciences</pub><pmid>21060742</pmid><doi>10.3346/jkms.2010.25.11.1553</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1011-8934
ispartof Journal of Korean Medical Science, 2010, 25(11), 144, pp.1553-1559
issn 1011-8934
1598-6357
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_573971
source PubMed (Medline)
subjects Heparin, Low-Molecular-Weight - therapeutic use
Humans
Polysaccharides - therapeutic use
Republic of Korea
Risk Factors
Special
Venous Thromboembolism - prevention & control
Venous Thromboembolism - surgery
Venous Thromboembolism - therapy
Warfarin - therapeutic use
의학일반
title Korean guidelines for the prevention of venous thromboembolism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A59%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Korean%20guidelines%20for%20the%20prevention%20of%20venous%20thromboembolism&rft.jtitle=Journal%20of%20Korean%20medical%20science&rft.au=Bang,%20Soo-Mee&rft.aucorp=Korean%20Society%20of%20Thrombosis%20and%20Hemostasis&rft.date=2010-11-01&rft.volume=25&rft.issue=11&rft.spage=1553&rft.epage=1559&rft.pages=1553-1559&rft.issn=1011-8934&rft.eissn=1598-6357&rft_id=info:doi/10.3346/jkms.2010.25.11.1553&rft_dat=%3Cproquest_nrf_k%3E763256118%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-4a10a6297874df0d20859b5089b7e856db47c53cfd99322d385b22898f3b5e723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=763256118&rft_id=info:pmid/21060742&rfr_iscdi=true